Evaluating the effects of carbon monoxide releasing molecule-2 against myocardial ischemia–reperfusion injury in ovariectomized female rats
- 2 August 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie
- Vol. 394 (10), 2103-2115
- https://doi.org/10.1007/s00210-021-02129-8
Abstract
Purpose Cardioprotective effect of carbon monoxide, a gasotransmitter against myocardial ischemia–reperfusion injury (I/R), is well established in preclinical studies with male rats. However, its ischemic tolerance in post-menopausal animals has not been examined due to functional perturbations at the cellular level. Methods The protective role of carbon monoxide releasing molecule-2 (CORM-2) on myocardial I/R was studied in female Wistar rats using the Langendorff apparatus. The animals were randomly divided into normal and ovariectomized (Ovx) female rats and were maintained 2 months post-surgery. Each group was further divided into 4 subgroups (n = 6/subgroup): normal, I/R, CORM-2-control (20 μmol/L), and CORM-2-I/R. The cardiac injury was estimated via myocardial infarct size, lactate dehydrogenase, and creatine kinase levels in coronary effluent and cardiac hemodynamic indices. Mitochondrial functional activity was assessed by measuring mitochondrial electron transport chain enzyme activities, swelling behavior, mitochondrial membrane potential, and oxidative stress. Results Hemodynamic indices were significantly lower in ovariectomized rat hearts than in normal rat hearts. Sixty minutes of reperfusion of ischemic heart exhibited deteriorated cardiac physiological recovery in both ovariectomized and normal groups, where prominent decline was observed in ovariectomized rat. However, preconditioning the isolated heart with CORM-2 improved hemodynamics parameters significantly in both ovariectomized and normal rat hearts challenged with I/R, but with a limited degree of protection in ovariectomized rat hearts. The protective effect of CORM-2 was further confirmed via a reduction in cardiac injury, preservation of mitochondrial enzymes, and reduction in oxidative stress in all groups. Conclusion CORM-2 administration significantly attenuated myocardial I/R injury in ovariectomized rat hearts by attenuating I/R-associated mitochondrial perturbations and reducing oxidative stress.Keywords
This publication has 47 references indexed in Scilit:
- Carbon monoxide releasing molecule-2 attenuated ischemia/reperfusion-induced apoptosis in cardiomyocytes via a mitochondrial pathwayMolecular Medicine Reports, 2013
- Beneficial effect of prolonged heme oxygenase 1 activation in a rat model of chronic heart failureDisease Models & Mechanisms, 2013
- Mechanism(s) involved in carbon monoxide-releasing molecule-2-mediated cardioprotection during ischaemia-reperfusion injury in isolated rat heartIndian Journal of Pharmaceutical Sciences, 2012
- Mitochondrial Permeability Transition Pore and Calcium HandlingPublished by Springer Science and Business Media LLC ,2011
- Beneficial effects of carbon monoxide-releasing molecule-2 (CORM-2) on acute doxorubicin cardiotoxicity in mice: Role of oxidative stress and apoptosisToxicology and Applied Pharmacology, 2011
- Evaluation of the Mitochondrial Respiratory Chain and Oxidative Phosphorylation System Using Polarography and Spectrophotometric Enzyme AssaysCurrent Protocols in Human Genetics, 2009
- Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized ratsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Estrogen-related receptor α is essential for the expression of antioxidant protection genes and mitochondrial functionBiochemical and Biophysical Research Communications, 2007
- Carbon Monoxide Protects Against Cardiac Ischemia—Reperfusion Injury In Vivo via MAPK and Akt—eNOS PathwaysArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Heat stability and kinetic properties of human serum glutathione reductase activity in various disease statesBiochemical Medicine, 1981